Methotrexate Injection, Solution
Product Images NDC 46708-712

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 46708-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methotrexate-2ml-carton-alembic-ltd (Methotrexate 2ml Carton Alembic Ltd)

Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) is an isotonic liquid injection solution. The label states that it is for intravenous, intramuscular, and subcutaneous use only. The product is packaged in 5 x 2 mL multiple-dose vials and is labeled by Alembic Pharmaceuticals Limited. The label also highlights a preservative content and warns it is not for intrathecal use.*

FDA Label Image

Methotrexate-2ml-label-alembic-ltd (Methotrexate 2ml Label Alembic Ltd)

Label for Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) isotonic liquid in a 2 mL multiple-dose vial by Alembic Pharmaceuticals Limited. The label indicates the drug is a hazardous, preservative-containing solution for intravenous, intramuscular, and subcutaneous use. It also includes a barcode, lot, and expiration placeholders.*

FDA Label Image

Methotrexate-40ml-carton-alembic-ltd (Methotrexate 40ml Carton Alembic Ltd)

Packaging label for Methotrexate Injection, USP 1 g/40 mL (25 mg/mL) preservative-free solution for injection. The label indicates the product is by Alembic Pharmaceuticals Limited and intended for intravenous, intramuscular, subcutaneous, and intrathecal use. It includes storage instructions, warnings, and a barcode. The vial count is 1 x 40 mL single-dose vial. The label also highlights the product as a hazardous drug and sterile.*

FDA Label Image

Methotrexate-40ml-label-alembic-ltd (Methotrexate 40ml Label Alembic Ltd)

Label for Methotrexate Injection, USP 25 mg/mL (1 g/40 mL) by Alembic Pharmaceuticals Limited. The sterile, preservative-free solution is intended for intravenous, intramuscular, subcutaneous, and intrathecal use. The single-dose vial contains 40 mL and is marked as a hazardous drug with storage instructions and manufacturer details from Gujarat, India.*

FDA Label Image

Methotrexate-structure (Methotrexate Structure)

Chemical structure of methotrexate, the active ingredient in the Methotrexate injection solution. The diagram shows the molecule's atomic connections and arrangement as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.